The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) for patients with advanced biliary carcinoma as a postoperative adjuvant chemotherapy.
Yuji Morine
No relevant relationships to disclose
Mitsuo Shimada
No relevant relationships to disclose
Toru Utsunomiya
No relevant relationships to disclose
Satoru Imura
No relevant relationships to disclose
Tetsuya Ikemoto
No relevant relationships to disclose
Jun Hanaoka
No relevant relationships to disclose
Koji Sugimoto
No relevant relationships to disclose
Yu Saito
No relevant relationships to disclose
Shinichiro Yamada
No relevant relationships to disclose
Michihito Asanoma
No relevant relationships to disclose